Dermapharm Holding SE
XHAM:DMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dermapharm Holding SE
XHAM:DMP
|
DE |
|
L
|
Lunit Inc
KOSDAQ:328130
|
KR |
|
M
|
Magis SpA
MIL:MGS
|
IT |
|
Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX
|
CA |
|
K
|
Keppel Corporation Ltd
XMUN:KEP1
|
SG |
|
Clearone Inc
NASDAQ:CLRO
|
US |
|
C
|
Clariant AG
XMUN:CLRN
|
CH |
|
S
|
Sensata Technologies Holding PLC
XBER:S94
|
US |
|
I
|
Israel Discount Bank Ltd
TASE:DSCT
|
IL |
|
S
|
Scansource Inc
F:SC3
|
US |
|
Wells Fargo & Co
NYSE:WFC
|
US |
|
E
|
EOG Resources Inc
XMUN:EO5
|
US |
|
Siemens AG
XETRA:SIE
|
DE |
|
Vocento SA
MAD:VOC
|
ES |
|
C
|
Capgemini SE
XHAM:CGM
|
FR |
|
LVMH Moet Hennessy Louis Vuitton SE
XETRA:MOH
|
FR |
|
C
|
Cdon AB
F:64W
|
SE |
|
S
|
Stora Enso Oyj
XMUN:ENUR
|
FI |
|
T
|
Transurban Group
OTC:TRAUF
|
AU |
Bankruptcy Probability
Dermapharm Holding SE's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dermapharm Holding SE Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Dermapharm Holding SE
XETRA:DMP
|
2.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
641.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
325.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
247.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
200.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
224.9B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dermapharm Holding SE's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dermapharm Holding SE has total debt of 916.3m EUR. This includes both short-term (0 EUR) and long-term (916.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
